For citations:
Zhuravleva M.V., Kokushkin K.A., Luchinin E.A., Luchinina E.V., Kameneva T.R., Kuznetsova E.V., Krysanova V.S., Makarova E.V., Zhukova L.G. Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(4):537-549. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.220

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.